Skip to content

Effect of fenugreek on blood cholesterol and other lipids in patients with diabetes

Effect of fenugreek on postprandial triglycerides in patients with type 2 diabetes mellitus and mild to moderate hypertriglyceridemia - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062691
Enrollment
110
Registered
2024-02-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: Fenugreek: Fenugreek seed powder given in maximally tolerated dose ranging from 5-15 gm per day Control Intervention1: Placebo: Placebo would consist of sachets containing suji powder o

Sponsors

Dr S V Madhu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Mild to moderate hypertriglyceridemia( serum triglycerides more than 150 but less than 500 mg per dl 2.On a stable dose of statins for three months or not on statins 3. BMI more than 25 kilograms per square meters

Exclusion criteria

Exclusion criteria: 1. Any lipid lowering therapy other than statins 2. Hypothyroidism or hyperthyroidism 3. History of any macrovascular complications of diabetes including coronary artery disease, cerebrovascular disease of peripheral arterial disease 4. Pregnancy or lactation 5. History of cancer, pancreatitis, or any major illness of the liver, kidney and central nervous system 6. Subjects on systemic glucocorticoids, beta blockers, thiazides and nicotinic acid

Design outcomes

Primary

MeasureTime frame
Postprandial triglyceride levels in fenugreek and control group Timepoint: After 90 days of study intervention

Secondary

MeasureTime frame
Change in fasting & post prandial glucose, Change in weight, Change in waist circumference,Change in fasting triglycerides Timepoint: End of study (90 days)

Countries

India

Contacts

Public ContactProf SV Madhu

UCMS & GTB Hospital, Delhi

drsvmadhu@gmail.com9871891018

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026